StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
REVB

Revelation Biosciences, Inc.

REVBW Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.01
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$38.3K
Revenue (TTM)
Net income (TTM)
-$9.87M
EPS (TTM)
$-1.32
P/E ratio
Dividend yield
Free cash flow
-$8.29M
Cash
$14.1M
Total assets
$15.0M
Gross margin
52-week range
$0.01 – $0.01

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Jul 13, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 24, 2026 8-K Other events Jun 1, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Modified rights of security holders; Shareholder vote results Mar 19, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders Jan 29, 2026 8-K Other events Jan 22, 2026 8-K Modified rights of security holders; Shareholder vote results; Other events Dec 3, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Regulation FD disclosure Oct 29, 2025 8-K Regulation FD disclosure Oct 15, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Other events Sep 15, 2025 8-K Other events Sep 9, 2025 8-K Results of operations (earnings release) Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jul 9, 2025 8-K Shareholder vote results; Other events Jun 25, 2025 8-K Entered a material agreement; Modified rights of security holders; Other events Jun 4, 2025 8-K Director or officer change; Other events May 28, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Other events Mar 17, 2025 8-K Results of operations (earnings release) Mar 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Other events Feb 24, 2025 8-K Other events Feb 11, 2025 8-K Modified rights of security holders; Amended charter or bylaws Jan 30, 2025 8-K Shareholder vote results; Other events Jan 21, 2025 8-K Delisting notice or listing-rule failure; Other events Jan 7, 2025 8-K Other events Dec 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Other events Dec 6, 2024 8-K Results of operations (earnings release) Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Delisting notice or listing-rule failure Oct 21, 2024 8-K Other events Sep 27, 2024 10-Q/A Quarter ended 2024-06-30 Sep 23, 2024